Skip to main content
. 2016 Oct 17;6:35372. doi: 10.1038/srep35372

Figure 2. The target CFL1 and protein quantifications were validated.

Figure 2

(A) The dynamic results revealed that CFL1 was significantly upregulated in angiotensin-(1-7)-treated HAECs and attenuated by the Mas-receptor antagonist A779. (B) The expression of Cofilin-1 increased significantly in the groups treated with angiotensin for 6 h or 24 h and was also attenuated by A779 pre-treatment. The data are expressed as the mean ± SEM for three independent experiments. *p < 0.05 indicates a significant difference relative to the control (n = 5).